Clinical Trials Arena August 5, 2024
GlobalData

Eximia’s resources coupled with Tidewater’s capabilities and patient database are expected to enhance trial experiences.

Eximia Research Network has announced the acquisition of Tidewater Clinical Research, marking a significant expansion of its national clinical trial site network.

Established in 1994, Tidewater Clinical Research focuses on Women’s Health and Ophthalmology clinical trials in the Hampton Roads/Eastern Virginia region in the US.

The integration of Tidewater’s capabilities and patient database with Eximia’s extensive resources is expected to enhance clinical trial experiences.

Tidewater owner Kelley Fleming said: “Tidewater Clinical Research is proud to announce our integration into the Eximia Research Network, marking a significant step forward in enhancing clinical research accessibility and quality of care for diverse patient populations.”

Tidewater co-owner April Rusch...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Clinical Trials, Mergers & Acquisitions / JV, Trends
Transforming Clinical Trials with Alexander Saint-Amand
The New Product Development Landscape: Navigating the Challenges
Lindus Health completes $55m funding round
Bridging Clinical Research Gaps: How Site Augmentation Enhances Trial Success
Key Lead Generation Providers and Technology Solutions for the Clinical Trials Industry

Share This Article